skip to main content

    Updated Visitor Guidelines

 

MENU

 

Pancreatic Tumor-associated Macrophages Resist Chemotherapy

Gemcitabine, a front-line chemotherapy drug given to patients with pancreatic cancer, is made less effective because similar compounds released by tumor-associated immune cells block the drug’s action, research led by the University of Michigan Rogel Cancer Center found.

How The Cancer Genome Atlas Will Shape the Future of Cancer Research

Thirteen years after its initial funding, The Cancer Genome Atlas (TCGA) has analyzed 2.5 petabytes of data representing 33 different types of cancer. A series of 27 papers publishing across the Cell Press family of journals summarizes its final project, PanCancerAtlas, the most comprehensive cross-cancer genomic analysis available.

Many Ovarian Cancer Patients are Undertested for Genetic Mutations

Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a study by researchers at the Stanford University School of Medicine and several other organizations.

Improving Bone Marrow Transplant Patient Outcomes

In a surprising finding, researchers at the Rogel Cancer Center showed the protein NLRP6 aggravated the difficult symptoms of gastrointestinal graft-vs.-host disease (GVHD). Knocking out this protein in mice led to significantly better survival and less severe GVHD.

Looking for the link between diet and cancer

The foods that people in other countries put on their plates could teach Americans how to reduce their cancer risk. In a global tour under the Fulbright Global Scholar Award, Michigan Medicine cancer researcher Zora Djuric, Ph.D., is studying eating habits in Serbia, Guatemala and Australia.

Rogel Cancer Center Infusion Pharmacy Renovations

Rogel Cancer Center Infusion Pharmacy Renovation begins March 18 and continues through Fall 2019. Renovations WILL NOT impact the Outpatient Pharmacy, and we will continue to offer infusion at the Rogel Cancer Center.

Pages